Carlyle Group Inc. Q2 2023 Filing
Filed August 4, 2023
Portfolio Value
$2807.3T
Holdings
26
Report Date
Q2 2023
Filing Type
13F-HR
All Holdings (26 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | QDELQuidelortho Corp | 12,460,183 | $1032.5T | 36.78% | |
| 2 | GTMZoomInfo Technologies Inc | 36,662,469 | $930.9T | 33.16% | |
| 3 | MKSIMKS Instrs Inc | 3,482,732 | $376.5T | 13.41% | |
| 4 | VTRUVitru Ltd | 6,246,471 | $100.1T | 3.57% | |
| 5 | VRNAVerona Pharma Plc | 2,457,500 | $51.9T | 1.85% | |
| 6 | PHATPhathom Pharmaceuticals Inc | 3,496,808 | $50.1T | 1.78% | |
| 7 | GETYGetty Images Holdings Inc | 9,976,300 | $48.7T | 1.73% | |
| 8 | GDSGDS Hldgs Ltd | 4,072,624 | $44.8T | 1.59% | |
| 9 | VERAVera Therapeutics Inc | 2,416,837 | $38.8T | 1.38% | |
| 10 | HLVXHillevax Inc | 1,838,486 | $31.5T | 1.12% | |
| 11 | OKURReneo Pharmaceuticals Inc | 2,698,957 | $17.7T | 0.63% | |
| 12 | INVHInvitation Homes Inc | 477,500 | $16.4T | 0.59% | |
| 13 | SMHISeacor Marine Hldgs Inc | 1,314,164 | $15.0T | 0.54% | |
| 14 | JSPRJasper Therapeutics Inc | 8,761,891 | $11.8T | 0.42% | |
| 15 | CUBECubeSmart | 220,500 | $9.8T | 0.35% | |
| 16 | SPRBSpruce Biosciences Inc | 2,896,518 | $6.2T | 0.22% | |
| 17 | TORCEURAdicet Bio Inc | 2,115,385 | $5.1T | 0.18% | |
| 18 | SLNOSoleno Therapeutics Inc | 1,201,506 | $5.1T | 0.18% | |
| 19 | EMSmart Sh Global Ltd | 4,810,209 | $4.7T | 0.17% | |
| 20 | EFTREffector Therapeutics Inc | 4,822,114 | $4.0T | 0.14% | |
| 21 | —Nucana Plc | 3,333,333 | $2.6T | 0.09% | |
| 22 | —Paratek Pharmaceuticals Inc | 1,041,131 | $2.3T | 0.08% | |
| 23 | XCUREURExicure Inc | 281,636 | $368.9B | 0.01% | |
| 24 | —Meta Data Limited | 314,400 | $336.4B | 0.01% | |
| 25 | AGLEUSDAeglea Biotherapeutics Inc | 240,500 | $108.2B | 0.00% | |
| 26 | —Molecular Templates Inc | 200,000 | $92.0B | 0.00% |